Evolent Health Acquires IPG from TPG Growth for $375M

June 29, 2022

Evolent Health agreed to acquire IPG, a provider of surgical cost management solutions for musculoskeletal conditions, from TPG Growth for $375 million in cash plus up to $87 million of contingent consideration. The IPG platform will be integrated into Evolent’s New Century Health business to expand the company's value-based specialty care capabilities and add new payer and ambulatory surgery center relationships; the deal is expected to be immediately accretive to adjusted EBITDA.

Targets
IPG
Sellers
TPG Growth
Location
Georgia, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.